Correlation Between Abm Investama and Diagnos Laboratorium

Can any of the company-specific risk be diversified away by investing in both Abm Investama and Diagnos Laboratorium at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Abm Investama and Diagnos Laboratorium into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Abm Investama Tbk and Diagnos Laboratorium Utama, you can compare the effects of market volatilities on Abm Investama and Diagnos Laboratorium and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Abm Investama with a short position of Diagnos Laboratorium. Check out your portfolio center. Please also check ongoing floating volatility patterns of Abm Investama and Diagnos Laboratorium.

Diversification Opportunities for Abm Investama and Diagnos Laboratorium

0.89

Correlation Coefficient

Abm Investama  Diagnos Laboratorium

Very poor diversification

The 3 months correlation between Abm and Diagnos is 0.89. Overlapping area represents the amount of risk that can be diversified away by holding Abm Investama Tbk and Diagnos Laboratorium Utama in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Diagnos Laboratorium and Abm Investama is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Abm Investama Tbk are associated (or correlated) with Diagnos Laboratorium. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Diagnos Laboratorium has no effect on the direction of Abm Investama i.e., Abm Investama and Diagnos Laboratorium go up and down completely randomly.

Pair Corralation between Abm Investama and Diagnos Laboratorium

Assuming the 90 days trading horizon Abm Investama Tbk is expected to generate 0.57 times more return on investment than Diagnos Laboratorium. However, Abm Investama Tbk is 1.75 times less risky than Diagnos Laboratorium. It trades about -0.13 of its potential returns per unit of risk. Diagnos Laboratorium Utama is currently generating about -0.12 per unit of risk. If you would invest  422,000  in Abm Investama Tbk on September 17, 2024 and sell it today you would lose (71,000) from holding Abm Investama Tbk or give up 16.82% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

Abm Investama Tbk  vs.  Diagnos Laboratorium Utama

Abm Investama Tbk

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Abm Investama Tbk has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's forward-looking signals remain quite persistent which may send shares a bit higher in January 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Diagnos Laboratorium

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Diagnos Laboratorium Utama has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's forward-looking signals remain quite persistent which may send shares a bit higher in January 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Pair Trading with Abm Investama and Diagnos Laboratorium

The main advantage of trading using opposite Abm Investama and Diagnos Laboratorium positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Abm Investama position performs unexpectedly, Diagnos Laboratorium can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Diagnos Laboratorium will offset losses from the drop in Diagnos Laboratorium's long position.

The idea behind Abm Investama Tbk and Diagnos Laboratorium Utama pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.